Is CoreCivic (CXW) overvalued or fairly valued?

MarketChacha shows CoreCivic's valuation in context — a trailing P/E of about 22.5, a forward P/E of about 12.5, a price-to-book of about 2.1 — alongside its revenue and profit growth and whether reported profit converts into operating cash, so you can judge value for yourself. MarketChacha does not issue ratings, price targets, or buy/sell advice.

Does CoreCivic's reported profit turn into cash?

Over 3 years, operating cash flow fully covered reported profit — earnings are backed by real cash. MarketChacha computes this cash-conversion check (2.75×) from reported figures — education, not a rating.

What is CoreCivic's revenue?

CoreCivic reported revenue of $2.2B for FY2025, with net profit of $116.5M, per official filings.

What is the share price of CoreCivic (CXW)?

CoreCivic last traded at $30.19 (+1.0% on the day), as of 10/20/2026 — a delayed quote shown for education, not investment advice.

CoreCivic

CXW · NYSE · Industrials · United States

Snapshot

TickerCXW

ExchangeNYSE

SectorIndustrials

IndustrySecurity & Protection Services

CountryUnited States

Employees13,651

HeadquartersBrentwood, United States

Websitewww.corecivic.com

Filings tracked20

About CoreCivic

CoreCivic, Inc. owns and operates partnership correctional, detention, and residential reentry facilities in the United States. It operates through three segments: CoreCivic Safety, CoreCivic Community, and CoreCivic Properties. The company provides a range of solutions to government partners that serve the public good through corrections and detention management, a network of residential reentry centers to help address recidivism crisis, and government real estate solutions. Its correctional, detention, and residential reentry facilities offer rehabilitation and educational programs, including basic education, faith-based services, life skills and employment training, and substance abuse treatment; food services; and work and recreational programs as well as health care services, including medical, dental, and mental health services. The company was founded in 1983 and is based in Brentwood, Tennessee.

Who owns it

Insiders2.2%
Institutions93.9%
Public & other4.0%

368 institutional holders

Ownership breakdown from public market data.

Top holders

Blackrock Inc.16.00%
River Road Asset Management, LLC7.33%
Vanguard Portfolio Management LLC6.91%
Goldman Sachs Group Inc4.73%
Vanguard Capital Management LLC4.33%
State Street Corporation3.84%
Assenagon Asset Management S.A.2.94%
Rubric Capital Management LP2.88%

Largest institutional holders — last updated 6/30/2026.

Forensic scorecard

No major accounting red flags in the fundamentals we have — profit is backed by cash and returns look healthy.

Cash conversion2.75×

Over 3 years, operating cash flow fully covered reported profit — earnings are backed by real cash.

Net margin trend3.6% → 5.3%

Margin has expanded by about 1.7 points — the business is getting more profitable.

Growth qualityrev 8% · PAT 31%

Profit growth is broadly tracking revenue growth — the earnings trend looks operational rather than one-off.

Computed by MarketChacha from reported figures (SEC XBRL). Education, not a rating or recommendation.

What's expected next

Next quarter

Rev $703.4M · EPS 0.47

Est. earnings growth +75.9%

Next fiscal year

Rev $2.9B · EPS 2.42

Est. earnings growth +43.7%

Analyst consensus estimates — not the company's own guidance.

New to these terms?

P/E ROE ROCE Margins Market cap

Browse the Learn hub →

Financials at a glance

Source: SEC XBRL

Annual

Quarterly · last 8

Revenue (FY2025)

$2.2B

Net margin

5.3%

ROE

8.3%

Revenue CAGR (2y)

+8.0%

Profit CAGR (2y)

+31.3%

EPS (FY2025)

1.08

Net profit (FY2025)

$116.5M

Ask MarketChacha about CXW

Get a cited, plain-English answer — the “why”, not just data. Finance research only, never buy/sell advice.

Financials

Yearly

Period	Revenue	Net profit	EPS	Net margin	ROE
FY2025	$2.2B	$116.5M	1.08	5.3%	8.3%
FY2024	$2.0B	$68.9M	0.62	3.5%	4.6%
FY2023	$1.9B	$67.6M	0.59	3.6%	4.6%

Quarterly

Period	Revenue	Net profit	EPS	Net margin
2026Q2	$684.9M	$37.1M	0.37	5.4%
2026Q1	$614.7M	$37.9M	0.38	6.2%
2025Q3	$580.4M	$26.3M	0.24	4.5%
2025Q2	$538.2M	$38.5M	0.35	7.2%
2025Q1	$488.6M	$25.1M	0.23	5.1%
2024Q3	$491.6M	$21.1M	0.19	4.3%
2024Q2	$490.1M	$19.0M	0.17	3.9%
2024Q1	$500.7M	$9.5M	0.08	1.9%
2023Q3	$483.7M	$13.9M	0.12	2.9%
2023Q2	$463.7M	$14.8M	0.13	3.2%
2023Q1	$458.0M	$12.4M	0.11	2.7%

Figures as reported, in reporting currency. Source: SEC XBRL.

Filings & announcements

2026

8-K — Reg FD disclosure, Other events, Exhibits
SEC8/10/2026material
10-Q filing
SEC8/6/2026
8-K — Results of operations, Other events, Exhibits
SEC8/5/2026material
8-K — Material agreement, Completion of acquisition/disposition, Reg FD disclosure, Exhibits
SEC8/5/2026material
8-K — Other events, Exhibits
SEC7/13/2026material
8-K — Material agreement, Completion of acquisition/disposition, Reg FD disclosure, Exhibits
SEC7/6/2026material
8-K — Shareholder vote results, Exhibits
SEC5/18/2026material
10-Q filing
SEC5/7/2026
8-K — Results of operations, Exhibits
SEC5/6/2026material
8-K — Material agreement, Material financial obligation, Exhibits
SEC4/10/2026material
10-K filing
SEC2/20/2026
8-K — Results of operations, Exhibits
SEC2/11/2026material

2025

8-K — Executive/director change, Reg FD disclosure, Exhibits
SEC12/12/2025material
8-K — Material agreement, Material financial obligation, Reg FD disclosure, Exhibits
SEC12/2/2025material
8-K — Reg FD disclosure, Other events, Exhibits
SEC11/10/2025material
10-Q filing
SEC11/6/2025
8-K — Results of operations, Exhibits
SEC11/5/2025material
8-K — Executive/director change, Reg FD disclosure, Exhibits
SEC8/18/2025material
10-Q filing
SEC8/7/2025
8-K — Results of operations, Exhibits
SEC8/6/2025material

In the news

Education and discussion only — not investment advice. Financials from official filings (SEC/BSE) and reported company statements; market figures (delayed market data) are delayed and shown for reference only. Verify with the linked sources before acting.